Peer Review, Publication Ethics and Malpractice Statement
General Principles
Diagnostic and Interventional Radiology (Diagn Interv Radiol) is the open access, online-only, double-blind peer-reviewed official publication of the Turkish Society of Radiology. The journal is published bimonthly and its publication language is English.
The editorial and publication processes of Diagnostic and Interventional Radiology are conducted in accordance with the recommendations and guidelines of the International Committee of Medical Journal Editors (ICMJE), World Association of Medical Editors (WAME), Council of Science Editors (CSE), Committee on Publication Ethics (COPE), European Association of Science Editors (EASE), National Information Standards Organization (NISO), and the Principles of Transparency and Best Practice in Scholarly Publishing.
Submitted manuscripts are considered on the condition that they have not been previously published and are not under simultaneous consideration elsewhere; that all authors have read and approved the manuscript; that all authors have disclosed potential conflicts of interest; and that the work complies with ethical approval, informed consent, research integrity, and publication ethics requirements.
Human and Animal Rights
For studies involving human participants, authors must state that the study was conducted in accordance with the latest revision of the World Medical Association Declaration of Helsinki. Ethics committee approval must be obtained from an institutional or regional ethics committee where applicable. The name of the ethics committee, approval date, and approval number/year must be provided in the Methods section.
Prospective human studies require both ethics committee approval and informed consent from participants. . Retrospective studies require ethics committee approval with a waiver of informed consent, unless otherwise determined by the responsible ethics committee. Authors may be required to provide documentation of approval or waiver.
For case reports and studies involving identifiable patient information, clinical images, or personal data, written informed consent must be obtained from the patient or legal representative. For individuals under 18 years of age, consent should be obtained from parents or legal guardians.
For experimental animal studies, authors must state that the procedures were conducted in accordance with relevant animal welfare regulations and guidelines, including the Guide for the Care and Use of Laboratory Animals, the 3Rs principles (Replacement, Reduction, and Refinement), and applicable national/international regulations. Animal ethics committee approval should be obtained and submitted where required.
Plagiarism, Similarity Screening, and Ethical Misconduct
All submissions are screened using similarity detection software, including iThenticate / Crossref Similarity Check. Manuscripts with an overall similarity index greater than 20%, or a duplication rate at or higher than 5% from a single source, are returned to authors without further evaluation together with the similarity report.
The journal considers the following practices to be forms of research or publication misconduct:
Plagiarism: Republishing whole or part of another author’s work without proper attribution.
Fabrication: Reporting data, findings, or results that do not exist.
Falsification: Manipulating research materials, equipment, processes, data, images, or results in a way that misrepresents the research record.
Duplication: Republishing the same study or substantial parts of the same study in another journal or language without appropriate disclosure, justification, permission, and citation.
Salami publication: Inappropriately dividing the results of a single study into multiple publications.
Citation manipulation: Inappropriate use of citations to influence citation metrics or misrepresent scholarly context.
Inappropriate authorship: Including individuals who do not meet authorship criteria, excluding individuals who do meet authorship criteria, or changing the author list without proper approval.
Peer-review manipulation: Attempting to manipulate or compromise the peer-review process, including fabricated reviewer identities, inappropriate reviewer suggestions, or undisclosed conflicts of interest.
When suspected misconduct is identified, the Editorial Board will conduct a confidential preliminary assessment in accordance with COPE flowcharts and guidance. Authors may be asked to provide explanations, raw data, ethics committee documents, informed consent forms, trial registration records, or other relevant documentation. When necessary, the journal may contact authors’ institutions, ethics committees, funders, or other journals. Formal investigations are the responsibility of the relevant institution or competent authority.
Multiple Submission and Withdrawal
Authors should not submit the same manuscript to more than one journal at the same time. Simultaneous submission of the same study to more than one journal is unacceptable and constitutes unethical behaviour.
Manuscripts may be withdrawn under certain circumstances, including violation of professional ethical codes, legal disputes, multiple submission, inappropriate authorship claims, plagiarism, misleading data, fabricated data, or findings that may pose a serious health risk.
The Editorial Board will follow COPE guidance in cases of manuscript withdrawal.
Duties of Editors
Peer Review
All submitted manuscripts first undergo technical and editorial evaluation by the editorial office, Editor-in-Chief, and/or assigned section editor. Manuscripts are assessed for compliance with journal guidelines, scope, originality, scientific merit, methodological quality, ethical compliance, and relevance to the readership.
Manuscripts considered suitable for further evaluation are subjected to double-blind peer review by at least two external and independent expert reviewers. Reviewers are expected to evaluate manuscripts objectively, confidentially, constructively, and in accordance with the COPE Ethical Guidelines for Peer Reviewers.
Reviewers and editors evaluate manuscripts without regard to the authors’ origin, gender, sexual orientation, political views, institutional affiliation, nationality, or any other personal characteristics.
All original research articles are also evaluated, by a senior statistical consultant for the appropriateness and consistency of data handling and statistical analysis.
The final decision on manuscripts is made by the Editor-in-Chief and/or assigned section editor based on reviewers’ comments, editorial assessment, ethical considerations, methodological quality, and the scientific merit of the manuscript.
Reviewers should not include definitive statements regarding acceptance or rejection in the “Comments to Authors” section during the initial evaluation. Final editorial decisions are made by the journal editors.
Unpublished materials disclosed in a submitted manuscript must not be used by editors, reviewers, editorial staff, or publisher representatives for personal advantage or for the advantage of others without the express written consent of the authors.
Editorial Process Transparency and Handling Editor Disclosure
For transparency in the editorial process, the name of the editor who handled the peer-review process of a published manuscript may be indicated in the article metadata. This information is provided solely to document editorial responsibility and should not be interpreted as authorship contribution, acknowledgement, endorsement, or conflict of interest.
When this information is included in the article, the preferred format is:
Handling Editor: Prof. Dr. [Name]
If applicable, a specific editorial role may also be indicated when relevant to the editorial process.
The handling editor information should not be included in the Acknowledgements section and should not be processed as an author, contributor, or collaborator in indexing, XML, or metadata records. It should be treated only as editorial process metadata.
Editors who have any personal, professional, institutional, academic, competitive, or financial conflict of interest with the manuscript, authors, or institutions must not take part in the editorial evaluation or decision-making process for that manuscript.
Conflicts of Interest and Disclosure
All sources of financial support, grants, institutional support, sponsorship, or material assistance received for the submitted work must be disclosed.
All authors must disclose any potential conflicts of interest that may influence, or be perceived to influence, the design, conduct, analysis, interpretation, writing, evaluation, or publication of the study. Potential conflicts may include financial relationships, employment, consultancies, stock ownership, honoraria, paid expert testimony, patents, personal relationships, academic competition, or intellectual beliefs.
The ICMJE Disclosure of Interest Form must be completed and submitted by all contributing authors. Conflict of interest and funding statements should appear at the end of the manuscript.
Reviewers must disclose any potential conflict of interest with the authors, institutions, funders, or subject matter of the manuscript and must decline review assignments where such conflicts exist.
Editors must recuse themselves from the evaluation and decision-making process if they have any personal, professional, institutional, academic, competitive, or financial conflict of interest with the manuscript, authors, or institutions involved. If the Editor-in-Chief, an associate editor, section editor, or editorial board member is an author of a submitted manuscript, that editor must be completely excluded from the editorial evaluation and decision-making process. In such cases, an independent guest editor or an editor with no conflict of interest will be assigned.
The Editorial Board evaluates potential conflicts of interest involving authors, reviewers, and editors in accordance with ICMJE recommendations on disclosure of financial and non-financial relationships and COPE guidance on conflicts of interest.
Undisclosed or unmanaged conflicts of interest may result in rejection of the manuscript, publication of a correction, expression of concern, or retraction, depending on the stage and severity of the case.
Appeals and Complaints
Appeals and complaints are handled by the Editorial Board in accordance with COPE guidance on appeals and complaints. Authors may appeal editorial decisions by submitting a detailed scientific justification. Appeals based solely on disagreement with the editorial decision, without new scientific or methodological arguments, may not be considered sufficient grounds for re-evaluation.
Authors wishing to submit an appeal or complaint should contact the Editorial Office and provide the manuscript title, manuscript number, detailed justification, and relevant supporting documentation.
Appeals are reviewed by the Editor-in-Chief or, where appropriate, by an editor who was not involved in the original decision. Additional reviewers, editorial board members, or external experts may be consulted if necessary. The final decision on appeals and complaints is made by the Editor-in-Chief.
Complaints regarding editorial process, publication ethics, peer review, conflicts of interest, corrections, or journal policies will be evaluated confidentially, fairly, and in a timely manner.
Post-Publication Discussions
Diagnostic and Interventional Radiology recognizes the importance of post-publication scholarly discussion and correction of the scientific record. Letters to the Editor, corrections, clarifications, editorial notes, expressions of concern, and retractions may be considered where appropriate.
Post-publication concerns will be evaluated in accordance with COPE guidance, COPE retraction guidelines, and ICMJE recommendations. Authors may be contacted for explanation or supporting documentation. Where necessary, the journal may communicate with institutions, ethics committees, funders, or other journals.
All editorial actions related to post-publication discussions, corrections, editorial notes, expressions of concern, or retractions will be documented clearly and linked to the relevant article where applicable.
Duties of Publisher
Corrections, Retractions, Editorial Notes, and Expressions of Concern
Diagnostic and Interventional Radiology is committed to maintaining the integrity and completeness of the scholarly record. When errors, ethical concerns, or publication misconduct are identified after publication, the Editorial Board will evaluate the case in accordance with COPE retraction guidelines, COPE guidance, and ICMJE recommendations on corrections and version control.
Corrections may be issued for errors that do not invalidate the findings or conclusions of the article. Retractions may be issued when there is clear evidence that findings are unreliable, the article involves research or publication misconduct, the article has been published elsewhere without appropriate justification, or the work includes unethical research.
An editorial note or expression of concern may be published when an investigation is ongoing, inconclusive, or when readers should be alerted to potentially serious concerns.
All correction, retraction, editorial note, and expression of concern notices will be clearly identified, linked to the original article, freely accessible, and indexed where applicable. Retracted articles will remain available with clear retraction labeling unless removal is required by legal reasons or serious health-risk considerations.
Crossmark Policy
Diagnostic and Interventional Radiology participates in Crossmark to maintain the integrity of the scholarly record and to alert readers to updates, corrections, retractions, editorial notes, or expressions of concern related to published articles.
All published articles receive a DOI and constitute part of the permanent scholarly record. When an article is corrected, retracted, or otherwise updated, the Crossmark record and the article landing page will direct readers to the current status of the article.
Open Access, Copyright, and Licensing
Diagnostic and Interventional Radiology provides immediate open access to its content. The journal’s open access policy is based on the principles of the Budapest Open Access Initiative (BOAI).
Articles published in Diagnostic and Interventional Radiology are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), unless otherwise stated on the journal website. Under this license, third parties may copy, distribute, and reuse the content for non-commercial purposes, provided that appropriate credit is given to the authors and the original work.
The copyright of the published article belongs to the author under the CC BY-NC 4.0 license. Authors agree to transfer the commercial rights to the Turkish Society of Radiology if the article is accepted for publication.
Permission is required for commercial use of published material. Republication or reproduction of images, tables, or other material should include proper citation of the source, including author name(s), article title, journal title, year, volume, page information, and copyright year where applicable.
Article Processing Charges
Diagnostic and Interventional Radiology applies an Article Processing Charge only for accepted articles. No fees are requested from authors during submission or evaluation.
The applicable APC amount is determined according to article type and the current fee table published on the journal website. The APC does not influence the editorial evaluation, peer-review process, editorial decision, or priority of manuscripts. All submissions are evaluated by the Editorial Board and external reviewers solely on the basis of scientific quality, methodological rigor, originality, relevance, and ethical standards.
Refund requests, are handled in accordance with the journal’s current APC and refund policy published on the journal website.
Digital Archiving and Preservation
Diagnostic and Interventional Radiology ensures long-term access to published content through website archiving, backup systems, abstracting and indexing services, and digital preservation arrangements. The journal’s archive is also preserved through PubMed Central (PMC) from 2014 publications onward.
Authors are permitted and encouraged to post their published articles on personal or institutional websites after publication, provided that full bibliographic details and a link to the original publication are included.
Advertising Policy
The journal’s advertising and editorial processes are strictly separated to ensure editorial independence and to reduce the influence of financial or commercial interests.
Editorial decisions are not influenced by advertising revenue, commercial considerations, sponsors, funders, or institutional relationships. Advertisers are responsible for ensuring that advertisements comply with applicable laws and ethical standards and do not contain deceptive, misleading, offensive, or unethical content.
Advertisements must be clearly distinguishable from editorial content.
Material Disclaimer
Statements or opinions expressed in articles published in the journal belong solely to the authors and do not necessarily reflect the views of the editors, Editorial Board, Turkish Society of Radiology, or publisher. The editors, Editorial Board, society, and publisher do not accept responsibility or liability for such materials.
